Dapoxetine-d7 hydrochloride

• CAT Number: S000154
• Molecular Formula: C21H17D7ClNO
• Molecular Weight: 348.92
• Purity: ≥95%
• Target: Serotonin Transporter
• IUPAC Name: (1S)-3-(2,3,4,5,6,7,8-heptadeuterionaphthalen-1-yl)oxy-N,N-dimethyl-1-phenylpropan-1-amine;hydrochloride
• InChI: InChI=1S/C21H23NO.ClH/c1-22(2)20(18-10-4-3-5-11-18)15-16-23-21-14-8-12-17-9-6-7-13-19(17)21;/h3-14,20H,15-16H2,1-2H3;1H/t20-;/m0./s1/i6D,7D,8D,9D,12D,13D,14D
• InChIKey: IHWDIQRWYNMKFM-WISGJDKSSA-N
• SMILES: [2H]C1=C(C(=C2C(=C1[2H])C(=C(C(=C2OCC[C@@H](C3=CC=CC=C3)N(C)C)[2H])[2H])[2H])[2H])[2H].Cl

Dapoxetine-d7 hydrochloride, a premium pharmaceutical research compound designed for advanced studies in premature ejaculation and sexual health. As a deuterated analog of Dapoxetine hydrochloride, it offers enhanced stability and improved pharmacokinetic properties. Dapoxetine-d7 hydrochloride is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for sexual health and premature ejaculation. Trusted by leading laboratories, Dapoxetine-d7 hydrochloride is your go-to solution for cutting-edge sexual health research. Unlock new possibilities in the treatment of premature ejaculation with Dapoxetine-d7 hydrochloride, where innovation meets reliability.

Reference

[1]. McMahon CG. Dapoxetine: a new option in the medical management of premature ejaculation. Ther Adv Urol. 2012 Oct;4(5):233-51.
[Content Brief]